APA (7th ed.) Citation

H, L., J, D., P, C., A, L., G, H., V, L., . . . E, Q. (2024). Patient-derived tumoroids and proteomic signatures: Tools for early drug discovery. Frontiers in immunology, 15, 1379613. https://doi.org/10.3389/fimmu.2024.1379613

Chicago Style (17th ed.) Citation

H, Lê, et al. "Patient-derived Tumoroids and Proteomic Signatures: Tools for Early Drug Discovery." Frontiers in Immunology 15 (2024): 1379613. https://doi.org/10.3389/fimmu.2024.1379613.

MLA (9th ed.) Citation

H, Lê, et al. "Patient-derived Tumoroids and Proteomic Signatures: Tools for Early Drug Discovery." Frontiers in Immunology, vol. 15, 2024, p. 1379613, https://doi.org/10.3389/fimmu.2024.1379613.